iSTAR Medical
iSTAR Medical Receives U.S. FDA Approval to Commence Pivotal Trial for MINIject in Glaucoma Patients
The STAR-V trial evaluates MINIject’s efficacy by the mean reduction in eye pressure, as well as the proportion of patients achieving at least a 20 percent reduction in eye pressure notes iSTAR Medical.
